<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Anesthesia for percutaneous cardiac valve interventions
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Anesthesia for percutaneous cardiac valve interventions
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Anesthesia for percutaneous cardiac valve interventions
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Mary Beth Brady, MD, FASE
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jonathan B Mark, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Stephen JD Brecker, MD, FRCP, FESC, FACC
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Nancy A Nussmeier, MD, FAHA
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Susan B Yeon, MD, JD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jan 29, 2024.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H2892286876">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Transcatheter approaches for the treatment of aortic, mitral, pulmonic, and tricuspid valve disease are less invasive than open surgical treatment options, often avoid the need for an open incision, and generally obviate the need for cardiopulmonary bypass (CPB). Aortic stenosis (AS) and mitral regurgitation (MR) are the most common cardiac valvular lesions requiring intervention in the United States and other developed countries.
        </p>
        <p>
         This topic will discuss anesthetic management of patients undergoing the following percutaneous cardiac valve interventions. Indications, technical approaches, and complications for specific percutaneous valve procedures are discussed in separate topics:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Aortic valve interventions
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Transcatheter aortic valve implantation (TAVI; also termed transcatheter aortic valve implantation [TAVI]) (see
         <a class="local">
          'Transcatheter aortic valve implantation'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/108265.html" rel="external">
          "Transcatheter aortic valve implantation: Periprocedural and postprocedural management"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/110074.html" rel="external">
          "Transcatheter aortic valve implantation: Complications"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         For native AS (and native aortic regurgitation [AR]) (see
         <a class="medical medical_review" href="/z/d/html/83110.html" rel="external">
          "Choice of intervention for severe calcific aortic stenosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8160.html" rel="external">
          "Natural history and management of chronic aortic regurgitation in adults", section on 'Investigational transcatheter alternative'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Valve-in-valve for bioprosthetic aortic valve dysfunction (see
         <a class="medical medical_review" href="/z/d/html/111633.html" rel="external">
          "Bioprosthetic valve thrombosis, thromboembolism, and obstruction: Management", section on 'Aortic valve-in-valve procedure'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/112653.html" rel="external">
          "Management and prognosis of surgical aortic and mitral prosthetic valve regurgitation", section on 'Aortic valve-in-valve procedure'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Percutaneous balloon aortic valvotomy (see
         <a class="local">
          'Percutaneous balloon aortic valvotomy'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/8141.html" rel="external">
          "Percutaneous balloon aortic valvotomy for native aortic stenosis in adults"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Mitral valve interventions
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Transcatheter edge-to-edge mitral repair (TEER) for MR (see
         <a class="medical medical_review" href="/z/d/html/99943.html" rel="external">
          "Transcatheter edge-to-edge mitral repair"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Percutaneous mitral balloon valvotomy for mitral stenosis (see
         <a class="medical medical_review" href="/z/d/html/8161.html" rel="external">
          "Percutaneous mitral balloon commissurotomy in adults"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Valve-in-valve implantation for bioprosthetic mitral valve dysfunction (see
         <a class="medical medical_review" href="/z/d/html/111633.html" rel="external">
          "Bioprosthetic valve thrombosis, thromboembolism, and obstruction: Management", section on 'Mitral valve-in-valve procedure'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/112653.html" rel="external">
          "Management and prognosis of surgical aortic and mitral prosthetic valve regurgitation", section on 'Mitral valve-in-valve procedure'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pulmonic valve interventions
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Percutaneous pulmonic valve implantation (PPVI) (see
         <a class="medical medical_review" href="/z/d/html/86481.html" rel="external">
          "Transcatheter pulmonary valve implantation"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Percutaneous pulmonic balloon valvotomy (see
         <a class="medical medical_review" href="/z/d/html/8118.html" rel="external">
          "Pulmonic valve stenosis in adults: Management", section on 'Balloon valvotomy'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Tricuspid valve intervention
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Transcatheter tricuspid valve repair or replacement (see
         <a class="local">
          'Transcatheter tricuspid valve repair'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/8145.html" rel="external">
          "Management and prognosis of tricuspid regurgitation", section on 'Transcatheter tricuspid valve repair'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Percutaneous tricuspid balloon valvotomy (see
         <a class="local">
          'Percutaneous tricuspid balloon valvotomy'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/8136.html" rel="external">
          "Tricuspid stenosis", section on 'For balloon valvotomy'
         </a>
         )
        </p>
        <p>
        </p>
        <p>
         The term "minimally invasive" valve surgery refers to a set of open cardiac surgical techniques that employ direct thoracoscopic or robotic approaches developed specifically for use of a smaller incision than the traditional median sternotomy approach to perform cardiac surgical interventions. Anesthetic and surgical management for minimally invasive surgical aortic and mitral valve procedures are addressed in separate topics:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/8128.html" rel="external">
          "Minimally invasive aortic and mitral valve surgery", section on 'Minimally invasive mitral valve surgery (MI-MVR)'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/8128.html" rel="external">
          "Minimally invasive aortic and mitral valve surgery", section on 'Minimally invasive aortic valve surgery (MI-AVR)'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/91483.html" rel="external">
          "Anesthesia for cardiac valve surgery", section on 'Minimally invasive mitral valve repair'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1061367110">
         <span class="h1">
          ANESTHETIC MANAGEMENT: GENERAL CONSIDERATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         General considerations for anesthetic planning and management of percutaneous valve interventions include the team, the procedure location, selection of anesthetic technique and agents, and timing and location of extubation and recovery.
        </p>
        <p class="headingAnchor" id="H1958295992">
         <span class="h2">
          Team and location
         </span>
         <span class="headingEndMark">
          —
         </span>
         These procedures require a multidisciplinary team, which typically includes an interventional cardiologist, cardiac surgeon, imaging specialist/radiologist, and cardiac anesthesiologist. While cardiopulmonary bypass (CPB) is not generally required for percutaneous valve procedures, a perfusionist should be available to provide back-up for CPB if needed.
        </p>
        <p>
         Whether a procedure is performed in a hybrid operating room or in the cardiac catheterization laboratory is dependent on a number of factors including whether the patient is a sternotomy candidate, the anticipated risk of surgical conversion, the availability of a hybrid setting, and institutional practice. According to the expert consensus statement for transcatheter aortic valve implantation (TAVI) procedures, a hybrid setting is preferred but is not mandatory if other standards are met [
         <a href="#rid1">
          1
         </a>
         ]. These requirements include specifications regarding room size; heating, ventilation, and air conditioning systems; lighting; power; ability to provide volatile anesthetics; and ability to operate various mechanical circulatory support devices (eg, CPB, extracorporeal membrane oxygenation, intra-aortic balloon pump).
        </p>
        <p class="headingAnchor" id="H1000704175">
         <span class="h2">
          Monitoring and team communication
         </span>
         <span class="headingEndMark">
          —
         </span>
         Whether the patient is receiving moderate sedation or general anesthesia, standard American Society of Anesthesiologists (ASA) monitors should be employed. These include monitoring the electrocardiogram, noninvasive blood pressure, oxygenation via pulse oximeter, temperature, and exhaled carbon dioxide monitoring (capnography). Capnography facilitates early detection of apnea and/or airway obstruction and predicts the development of hypoxemia during moderate sedation, and may reduce patient injury related to respiratory depression. If an intra-arterial catheter is placed by the interventionalist for the procedure, it is used for continuous monitoring of arterial blood pressure. Each of these monitors is described in detail in a separate topic. (See
         <a class="medical medical_review" href="/z/d/html/100067.html" rel="external">
          "Basic patient monitoring during anesthesia"
         </a>
         .)
        </p>
        <p>
         In all cases, frequent communication among team members is required to inform selection and dosing of vasoactive agents, determine whether ongoing interventional procedures are successful, and to rapidly recognize and treat new complications.
        </p>
        <p>
         Imaging (eg, fluoroscopy and echocardiography) during valve procedures is discussed in the sections below.
        </p>
        <p class="headingAnchor" id="H3235418846">
         <span class="h2">
          Selection of anesthesia technique
         </span>
         <span class="headingEndMark">
          —
         </span>
         The selected anesthetic technique for percutaneous cardiac valve interventions may be general anesthesia (loss of consciousness without arousability  (
         <a class="graphic graphic_table graphicRef109909" href="/z/d/graphic/109909.html" rel="external">
          table 1
         </a>
         )) with endotracheal intubation, monitored anesthesia care (MAC) with moderate or deep sedation (depressed consciousness with a preserved response to verbal stimulus), or nurse-administered sedation supervised by the interventionalist unless and until emergency anesthetic care becomes necessary [
         <a href="#rid2">
          2
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/264.html" rel="external">
          "Procedural sedation in adults in the emergency department: General considerations, preparation, monitoring, and mitigating complications"
         </a>
         .)
        </p>
        <p>
         Considerations in selecting the anesthetic technique include the specific valve procedure involved (as described in the sections below), operator and institutional experience and preferences, patient-specific factors (eg, orthopnea, obstructive sleep apnea, obesity, difficult airway, severe pulmonary disease, right heart dysfunction, inability to cooperate, anxiety, high baseline requirement for pain medications), and whether transesophageal echocardiography (TEE) use is planned (which typically requires general anesthesia and endotracheal intubation).
        </p>
        <p>
         Preoperative counseling for patients undergoing moderate sedation rather than general anesthesia should include explanations regarding use of local anesthesia, possible awareness during the procedure, expectations for a sensation of rapid ventricular pacing, and the possible need for conversion to general anesthesia [
         <a href="#rid3">
          3,4
         </a>
         ]. Also, the interventionalist should be aware that some patient movement may occur, and that intraprocedural imaging will generally be limited to fluoroscopy and transthoracic echocardiography (TTE).
        </p>
        <p>
         With either moderate sedation or general anesthesia, short-acting anesthetic agents are preferred. Local anesthetic is often injected at incision sites to lessen the anesthetic requirement. Normothermia should be maintained throughout the procedure to maintain patient comfort and ensure rapid awakening and recovery.
        </p>
        <p class="headingAnchor" id="H210690617">
         <span class="h3">
          Moderate sedation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Sedative and analgesic agents and doses for percutaneous valve procedures performed with MAC and moderate (or deep) sedation are similar to those selected for other types of procedures performed with MAC and moderate (or deep) sedation and local anesthetic infiltration.
        </p>
        <p>
         Anesthetic agents and doses are tailored to the individual patient. For MAC and moderate (or deep) sedation, agents initially administered by this author typically include a low dose
         <a class="drug drug_general" data-topicid="9854" href="/z/d/drug information/9854.html" rel="external">
          remifentanil
         </a>
         infusion or a low dose
         <a class="drug drug_general" data-topicid="8897" href="/z/d/drug information/8897.html" rel="external">
          dexmedetomidine
         </a>
         infusion. If needed, small dose(s) of intravenous (IV)
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          midazolam
         </a>
         are added. If an additional anesthetic agent is required to achieve the desired depth of sedation,
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         may be administered in small boluses or as an infusion added to the initial drug combination. One retrospective study compared the use of propofol versus remifentanil infusions to achieve sedation during TAVI procedures, noting that both agents were safe and effective, with similar rates of conversion to general anesthesia [
         <a href="#rid5">
          5
         </a>
         ]. However, remifentanil was associated with lower oxygen saturation nadir values, while propofol infusion was associated with a higher rate of vasopressor use. (See
         <a class="medical medical_review" href="/z/d/html/94529.html" rel="external">
          "Monitored anesthesia care in adults", section on 'Drugs used for sedation and analgesia for monitored anesthesia care'
         </a>
         .)
        </p>
        <p>
         If nurse-administered sedation is supervised by the interventionalist,
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          midazolam
         </a>
         plus
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         is typically used to provide light to moderate sedation.
        </p>
        <p>
         Use of adjuncts to maintain a patent airway such as an oral airway or a nasal trumpet is limited. An oral airway may not be well tolerated if the sedation level is light. A nasal trumpet could cause significant nasal bleeding due to anticoagulation with heparin during the procedure.
        </p>
        <p class="headingAnchor" id="H3112301133">
         <span class="h3">
          Conversion to general anesthesia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Some patients receiving moderate sedation are unable to cooperate during the procedure because of increasing anxiety, delirium, discomfort, shortness of breath, or development of hemodynamic instability. In such cases, conversion to general anesthesia is usually necessary [
         <a href="#rid6">
          6-8
         </a>
         ]. For this reason, back-up from the anesthesiology team is ideal for all percutaneous cardiac valve interventions to provide support if necessary. Considerations in such cases may include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Airway management
         </strong>
         – Access to the patient's head may be difficult due to the position of radiography and other equipment. A laryngeal mask airway (LMA) may be inserted in an emergency, but placement of an endotracheal tube (ETT) is generally preferable since repositioning of the fluoroscopy equipment and/or performance of cardiopulmonary resuscitation (CPR) may dislodge an LMA.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hemodynamic support
         </strong>
         – Hemodynamic support with infusion of a vasoconstrictor (eg,
         <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">
          phenylephrine
         </a>
         or vasopressin) or inotropic agent (eg, epinephrine or norepinephrine) may be necessary in some unstable patients  (
         <a class="graphic graphic_table graphicRef119747" href="/z/d/graphic/119747.html" rel="external">
          table 2
         </a>
         ). Central vascular access is preferred for administration of vasoactive infusions, but initiation of vasoactive infusions should not be delayed for placement of a central venous catheter (CVC). In this setting, emergent management of hemodynamic instability may be accomplished by infusing vasoactive agents through the side-arm of the femoral sheath previously inserted by the interventional cardiologist.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2633199430">
         <span class="h3">
          General anesthesia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Short-acting IV anesthetic agents such as
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         ,
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         or
         <a class="drug drug_general" data-topicid="9854" href="/z/d/drug information/9854.html" rel="external">
          remifentanil
         </a>
         ,
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          midazolam
         </a>
         ,
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          ketamine
         </a>
         , and/or a volatile inhalation anesthetic, as well as a short-acting neuromuscular blocking agent (NMBA) are preferred to facilitate rapid awakening and recovery after general anesthesia [
         <a href="#rid9">
          9
         </a>
         ]. Our induction sequence typically includes low doses of propofol and fentanyl administered with an NMBA. Maintenance is typically accomplished with
         <a class="drug drug_general" data-topicid="9887" href="/z/d/drug information/9887.html" rel="external">
          sevoflurane
         </a>
         and, if needed, additional doses of an NMBA.
        </p>
        <p class="headingAnchor" id="H1209298862">
         <span class="h2">
          Postoperative extubation and recovery
         </span>
         <span class="headingEndMark">
          —
         </span>
         Tracheal extubation after general anesthesia occurs in the procedure room after ensuring hemostasis (including neutralization of heparin given during the procedure), or, in some cases, shortly after the procedure. Notably, many patients undergoing percutaneous cardiac interventions must lie supine for four to six hours in the immediate postoperative period to reduce risk for groin hematoma or other vascular complications. This may impact comfort or respiratory mechanics in a critically ill patient. These factors are considered in decisions to perform extubation in the procedural room or a few hours later. Patients can often be transferred to a high-dependency setting rather than to an intensive care unit depending on type of procedure performed, anesthetic technique employed, preexisting patient factors, and potential for complications. In hospitals without stepdown or intermediate care units, a post-anesthesia care unit is often used for this purpose.
        </p>
        <p class="headingAnchor" id="H530080501">
         <span class="h1">
          AORTIC VALVE INTERVENTIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients with severe calcific native aortic stenosis (AS), selection of surgical aortic valve replacement (SAVR), transcatheter aortic valve implantation (TAVI)  (
         <a class="graphic graphic_figure graphicRef109286" href="/z/d/graphic/109286.html" rel="external">
          figure 1
         </a>
         ), or palliative medical therapy is based on estimated surgical risk and other factors. Indications for percutaneous balloon aortic valvotomy as a temporizing measure are very limited.
        </p>
        <p class="headingAnchor" id="H3376415723">
         <span class="h2">
          Transcatheter aortic valve implantation
         </span>
        </p>
        <p class="headingAnchor" id="H3102828569">
         <span class="h3">
          General considerations
         </span>
         <span class="headingEndMark">
          —
         </span>
         With expanding indications for TAVI, the number of TAVI procedures performed in the United States has increased, while the number of SAVR procedures has decreased [
         <a href="#rid10">
          10,11
         </a>
         ]. Choice of intervention (TAVI or SAVR) for severe AS is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/83110.html" rel="external">
          "Choice of intervention for severe calcific aortic stenosis"
         </a>
         .)
        </p>
        <p>
         Although approval in the United States is only for patients with AS, TAVI has also been used for selected patients with aortic regurgitation (AR) [
         <a href="#rid12">
          12
         </a>
         ]. In Europe, a transcatheter heart valve has been approved for use in patients who have native AR with high to prohibitive surgical risk. (See
         <a class="medical medical_review" href="/z/d/html/8160.html" rel="external">
          "Natural history and management of chronic aortic regurgitation in adults"
         </a>
         .)
        </p>
        <p>
         Transcatheter aortic valve-in-valve procedures are an alternative to redo sternotomy with redo SAVR for select patients with bioprosthetic valve dysfunction. These procedures are used for treatment of bioprosthetic stenosis or regurgitation or a combination of both. The decision to perform this procedure requires careful consideration of anatomic and patient-specific factors [
         <a href="#rid13">
          13
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/112653.html" rel="external">
          "Management and prognosis of surgical aortic and mitral prosthetic valve regurgitation", section on 'Aortic valve-in-valve procedure'
         </a>
         .)
        </p>
        <p>
         The transfemoral arterial approach is used in nearly all (&gt;95 percent) TAVI cases. For patients who are not candidates for the transfemoral approach due to unfavorable iliofemoral artery characteristics, the most common current alternatives are the subclavian/axillary approach, two transthoracic approaches (transaortic and transapical), transcaval, or a transcarotid approach. (See
         <a class="medical medical_review" href="/z/d/html/108265.html" rel="external">
          "Transcatheter aortic valve implantation: Periprocedural and postprocedural management", section on 'Access routes'
         </a>
         .)
        </p>
        <p>
         As center and operator experience has grown, there has been a move toward performing TAVI with a less invasive approach [
         <a href="#rid9">
          9,14,15
         </a>
         ]. While practice varies considerably, this approach includes performing the procedure under moderate sedation with local anesthesia (typically with monitored anesthesia care [MAC]), without transesophageal echocardiography (TEE), and with selective use of temporary pacing. (See
         <a class="local">
          'Anesthetic techniques and management'
         </a>
         below and
         <a class="local">
          'Imaging for TAVI procedures'
         </a>
         below.)
        </p>
        <p>
         Further discussions of technical aspects, preoperative and postoperative care, complications, and outcomes of the TAVI procedure are found in separate topics. (See
         <a class="medical medical_review" href="/z/d/html/108265.html" rel="external">
          "Transcatheter aortic valve implantation: Periprocedural and postprocedural management"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/110074.html" rel="external">
          "Transcatheter aortic valve implantation: Complications"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3643515066">
         <span class="h3">
          Imaging for TAVI procedures
         </span>
         <span class="headingEndMark">
          —
         </span>
         Fluoroscopy and angiography are used during TAVI procedures. Intraprocedural angiography is commonly combined with pre-implant, three-dimensional angiographic or multidetector computed tomography reconstructions to identify the optimal deployment projection. Intraprocedural echocardiography (transthoracic echocardiography [TTE]) or transesophageal echocardiography (TEE) is also commonly used [
         <a href="#rid16">
          16
         </a>
         ]. Significant inter-institutional heterogeneity exists regarding selection of imaging modalities for the critical phases of valve deployment and evaluation of its function immediately post-deployment. (See
         <a class="medical medical_review" href="/z/d/html/86447.html" rel="external">
          "Imaging for transcatheter aortic valve implantation"
         </a>
         .)
        </p>
        <p>
         TEE is used to provide technical guidance during positioning and insertion of the aortic valve, and to detect and quantify paravalvular leaks after deployment of the valve [
         <a href="#rid17">
          17,18
         </a>
         ]. Use of contrast media during fluoroscopy is typically avoided when TEE is used. TEE is also highly sensitive for detecting post-procedure paravalvular leaks, which are associated with risk for late mortality [
         <a href="#rid19">
          19-21
         </a>
         ]. Although fluoroscopy can detect presence or absence of a leak, precise localization of the leak and quantification of its significance (ie, mild, moderate, severe) is not always possible. However, improvements in device technology have reduced the risk of significant paravalvular leaks [
         <a href="#rid22">
          22
         </a>
         ]. Rapid detection of pericardial effusion is also possible with TEE (or TTE), but may be missed with fluoroscopy. (See
         <a class="medical medical_review" href="/z/d/html/86447.html" rel="external">
          "Imaging for transcatheter aortic valve implantation", section on 'Identifying complications'
         </a>
         .)
        </p>
        <p>
         Some institutions use only fluoroscopy for imaging during the procedure. An alternative is fluoroscopy use during the procedure with a limited transthoracic echocardiography examination (TTE) performed prior to and immediately after valve deployment to identify and evaluate the significance of any paravalvular leak and/or pericardial effusion.
        </p>
        <p class="headingAnchor" id="H1088507998">
         <span class="h3">
          Anesthetic techniques and management
         </span>
         <span class="headingEndMark">
          —
         </span>
         Selection of general anesthesia or moderate sedation with general anesthesia back-up for TAVI is based on careful assessment of the benefits and risks associated with each technique in an individual patient, including consideration of center and operator practice, patient comorbidities, planned use of TEE, and the TAVI access route [
         <a href="#rid4">
          4,6,9,17,23
         </a>
         ].
        </p>
        <p>
         There has been a trend toward greater use of moderate sedation with MAC rather than general anesthesia in centers in the United States and particularly in Europe [
         <a href="#rid24">
          24-26
         </a>
         ]. However, as a practical matter, general anesthesia is preferred when use of TEE is planned [
         <a href="#rid7">
          7,27
         </a>
         ]. Moderate sedation with MAC, can be utilized for TAVI when TEE is indicated, but a deeper level of sedation is required, with may increase the risk of hemodynamic and/or airway compromise. Broad indications for intraprocedural use of TEE include [
         <a href="#rid16">
          16
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Use of general anesthesia
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Poor acoustic TTE windows
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Uncertainty in valve sizing
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Concurrent procedures which require TEE
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Desire to limit the amount of contrast given
        </p>
        <p>
        </p>
        <p>
         Although most studies comparing general anesthesia versus moderate sedation with MAC and local or regional anesthetic techniques have focused on the transfemoral approach, a few reports have described successful use of the latter technique at alternative vascular access sites including transcarotid, subclavian, transcaval, or transapical approaches for TAVI (see
         <a class="medical medical_review" href="/z/d/html/108265.html" rel="external">
          "Transcatheter aortic valve implantation: Periprocedural and postprocedural management", section on 'Procedural considerations'
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A 2020 randomized trial in patients undergoing transfemoral TAVI compared outcomes in those who had local anesthesia together with moderate sedation with MAC versus general anesthesia with endotracheal intubation [
         <a href="#rid28">
          28
         </a>
         ]. A composite endpoint (all-cause mortality, stroke, myocardial infarction, infection requiring antibiotic treatment, and acute kidney injury at 30 days) occurred with similar incidence in the moderate sedation (27.2 percent of 222 patients) and general anesthesia groups (26.4 percent of 225 patients; rate difference [RD] 0.8, 90% CI -6.2 to 7.8). Patients receiving moderate sedation had a lower need for inotropes or vasopressors (63 versus 97 percent; RD -34, 90% CI -41 to -28). However, 12 patients receiving moderate sedation required urgent conversion to general anesthesia, and one additional patient required elective conversion for pain prophylaxis [
         <a href="#rid28">
          28
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Prior observational studies in patients undergoing transfemoral TAVI procedures identified better outcomes with moderate sedation (eg, lower 30 day mortality, reduced length of hospitalization) compared with general anesthesia [
         <a href="#rid3">
          3,4,15,27,29-31
         </a>
         ]. For example, in the National Cardiovascular Data Registry, which included nearly 11,000 patients, moderate sedation was employed in 16 percent, while general anesthesia was employed in 84 percent [
         <a href="#rid15">
          15
         </a>
         ]. Moderate sedation was associated with lower mortality (both in-hospital [1.5 versus 2.4 percent] and at 30 days [2.3 versus 4.0 percent), less intraprocedural inotrope use (29 versus 44 percent), and shorter hospital stay (6.0 versus 6.5 days) compared with general anesthesia. However, these observational studies have been limited by selection bias and lack of explicit definition of the type of anesthesia and role of the anesthesia care team [
         <a href="#rid15">
          15,27
         </a>
         ]. Classification in the general anesthesia group was typically based on whether the patient had an endotracheal tube, while the term "conscious sedation" usually referred to varying levels of anesthetic depth provided by an anesthesia care team (ie, MAC), although some studies included nurse-administered sedation supervised by the interventionalist.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The need for transfemoral surgical cutdown for TAVI is an indication for general anesthesia at some institutions. However, in one retrospective study of 282 TAVI patients, transfemoral surgical cutdown was performed using a regional anesthetic technique (ilioinguinal block) together with moderate sedation with MAC [
         <a href="#rid32">
          32
         </a>
         ]. In this study, the conversion rate to general anesthesia was only 3.9 percent, with a high procedural success rate of 99.3 percent.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Subclavian/axillary TAVI is usually performed with general anesthesia. However, regional anesthesia (eg, pectoralis plus interscalene blocks [
         <a href="#rid33">
          33
         </a>
         ] or superficial cervical plus interscalene blocks [
         <a href="#rid34">
          34
         </a>
         ]) together with moderate sedation with MAC has been described.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Transaortic or transapical TAVI is usually performed with general anesthesia. However, regional anesthesia (serratus anterior plane block) together with moderate sedation with MAC has been described for the transapical approach [
         <a href="#rid35">
          35
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Transcaval TAVI may be performed with either general anesthesia or with local anesthesia together with moderate sedation with MAC.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Transcarotid TAVI is typically performed with general anesthesia, although use of moderate sedation with MAC has been described. These procedures are performed in hybrid rooms with a multidisciplinary team that include anesthesiologists, interventional cardiologists, and cardiac surgeons. Prior to the procedure, some centers assess risk of cerebral hypoperfusion by cerebral magnetic resonance angiography screening and transcranial Doppler imaging [
         <a href="#rid36">
          36
         </a>
         ]. Cerebral perfusion can be continuously monitored during the procedure using cerebral oximetry with near infrared spectrometry [
         <a href="#rid36">
          36,37
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In a series of 174 patients undergoing a transcarotid approach, 30 day mortality, one year mortality, one month clinical efficacy, and early safety outcomes were similar in 122 patients receiving general anesthesia compared with 52 patients receiving moderate sedation [
         <a href="#rid37">
          37
         </a>
         ]. Periprocedural cerebrovascular events (ie, stroke or transient ischemic attack) were observed in 5.6 percent of those receiving general anesthesia, but in none of the smaller group receiving moderate sedation with MAC.
        </p>
        <p>
        </p>
        <p>
         Anesthetic management involves:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hemodynamic management
         </strong>
         – Key points for management of patients with AS undergoing an interventional procedure are summarized in the table  (
         <a class="graphic graphic_table graphicRef108941" href="/z/d/graphic/108941.html" rel="external">
          table 3
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Monitoring
         </strong>
         – Appropriate monitoring during a TAVI procedure is based in part on the selected anesthetic technique. Although invasive monitoring may be similar to that used for conventional SAVR procedures (eg, intra-arterial catheter and central venous catheter or pulmonary artery catheter) (see
         <a class="medical medical_review" href="/z/d/html/91483.html" rel="external">
          "Anesthesia for cardiac valve surgery", section on 'Surgery for aortic stenosis'
         </a>
         ), use of a full complement of these invasive cardiovascular monitors is decreasing [
         <a href="#rid9">
          9,24,38,39
         </a>
         ]. In fact, for TAVI procedures performed via a transfemoral approach (or for some alternative access routes) in low-risk patients, an intra-arterial catheter is not always necessary, especially if MAC is selected. Monitoring blood pressure via the intra-aortic sheath placed by the proceduralist (to be used for TAVI deployment) may suffice.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In patients undergoing general anesthesia, TEE is often employed to provide technical guidance, detect and quantify paravalvular leaks after valve deployment, and avoid use of contrast media during fluoroscopy [
         <a href="#rid17">
          17,18
         </a>
         ]. (See
         <a class="local">
          'Imaging for TAVI procedures'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Considerations for general anesthesia
         </strong>
         – Short-acting anesthetic agents selected for general anesthesia are described above. (See
         <a class="local">
          'General anesthesia'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Considerations for moderate sedation with MAC
         </strong>
         – Short-acting anesthetic agents selected for moderate sedation with MAC are carefully titrated to minimize the need for vasopressor and/or inotropic support and avoid postoperative respiratory depression as described above [
         <a href="#rid3">
          3,31,40-43
         </a>
         ]. (See
         <a class="local">
          'Moderate sedation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Usually, moderate sedation with MAC is administered by an anesthesia provider for a TAVI procedure [
         <a href="#rid9">
          9
         </a>
         ], although some centers use nurse-administered sedation, typically with back-up from the anesthesia care team [
         <a href="#rid2">
          2
         </a>
         ]. We favor the presence of an anesthesiologist during TAVI given the likelihood of development of hemodynamic instability in patients with advanced age, frailty, or significant comorbidities, as well as the possible need for conversion to general anesthesia [
         <a href="#rid6">
          6-8,15
         </a>
         ]. The American Association for Thoracic Surgery (AATS)/American College of Cardiology (ACC)/Society for Cardiovascular Angiography (SCA)/Society of Thoracic Surgeons (STS) expert consensus statement recommends that TAVI programs have a comprehensive multidisciplinary team that includes an anesthesiologist [
         <a href="#rid1">
          1
         </a>
         ]. Although an anesthesiologist may not be constantly present for every individual procedure, immediate availability is necessary to provide support when urgently needed. (See
         <a class="local">
          'Moderate sedation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Need for conversion from sedation to general anesthesia was 5.9 percent in a large observational study of nearly 11,000 TAVI patients in the National Cardiovascular Data Registry Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry [
         <a href="#rid15">
          15
         </a>
         ]. Reasons for conversion in this and other studies have included vascular complications, hemodynamic compromise, and respiratory failure (particularly in patients with preexisting lung disease) [
         <a href="#rid15">
          15,44-46
         </a>
         ]. (See
         <a class="local">
          'Selection of anesthesia technique'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Most low-risk patients without complications can be transferred to a high-dependency setting after moderate sedation with MAC, rather than to an intensive care unit after TAVI performed without general anesthesia.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H271987820">
         <span class="h2">
          Percutaneous balloon aortic valvotomy
         </span>
        </p>
        <p class="headingAnchor" id="H1887992443">
         <span class="h3">
          General considerations
         </span>
         <span class="headingEndMark">
          —
         </span>
         The use of percutaneous balloon aortic valvotomy plays an important role in the treatment of children, adolescents, and young adults with AS, although its use in older adults with severe symptomatic AS is very limited and is not considered to be definitive treatment. For selected older adults with severe symptomatic AS this technique is a potential option to serve as a bridge to SAVR or TAVI [
         <a href="#rid47">
          47
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8141.html" rel="external">
          "Percutaneous balloon aortic valvotomy for native aortic stenosis in adults", section on 'Use'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2950874245">
         <span class="h3">
          Anesthetic techniques and management
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most centers undertake this procedure in adult patients using local anesthesia and light-to-moderate sedation, commonly administered by a nurse under the supervision of the interventional cardiologist. If a potentially life-threatening complication occurs, immediate availability of the anesthesia care team is critical to provide urgent endotracheal intubation and hemodynamic support [
         <a href="#rid48">
          48
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8141.html" rel="external">
          "Percutaneous balloon aortic valvotomy for native aortic stenosis in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1924451492">
         <span class="h1">
          MITRAL VALVE INTERVENTIONS
         </span>
        </p>
        <p class="headingAnchor" id="H3765710557">
         <span class="h2">
          Transcatheter edge-to-edge mitral repair
         </span>
        </p>
        <p class="headingAnchor" id="H2376497059">
         <span class="h3">
          General considerations
         </span>
         <span class="headingEndMark">
          —
         </span>
         For treatment of mitral regurgitation (MR), a potential advantage of transcatheter edge-to-edge mitral repair (TEER) "beating heart" approach rather than open cardiac surgical repair is the ability to use real-time transesophageal echocardiography (TEE) to assess adequacy of correction of MR so that immediate intra-procedural adjustments may be made if necessary.
        </p>
        <p>
         The MitraClip procedure and the PASCAL procedure are FDA-approved devices to create an edge-to-edge repair  (
         <a class="graphic graphic_figure graphicRef116916" href="/z/d/graphic/116916.html" rel="external">
          figure 2
         </a>
         ) (see
         <a class="medical medical_review" href="/z/d/html/99943.html" rel="external">
          "Transcatheter edge-to-edge mitral repair", section on 'Available technology'
         </a>
         ), resulting in double orifice mitral valve similar to that achieved after an Alfieri stitch performed during an open cardiac surgical procedure  (
         <a class="graphic graphic_figure graphicRef114893" href="/z/d/graphic/114893.html" rel="external">
          figure 3
         </a>
         ) [
         <a href="#rid49">
          49-54
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/91483.html" rel="external">
          "Anesthesia for cardiac valve surgery", section on 'Surgical mitral valve repair or replacement'
         </a>
         ). Other investigational devices for TEER are described separately. (See
         <a class="medical medical_review" href="/z/d/html/99943.html" rel="external">
          "Transcatheter edge-to-edge mitral repair", section on 'Investigational technologies'
         </a>
         .)
        </p>
        <p>
         Vascular access is obtained via transfemoral venous cannulation and a transseptal approach to the left atrium. Positioning of the transseptal puncture is critical to ensure that the mitral valve device can be maneuvered into the appropriate location. When the device is optimally positioned in the left ventricle, the mitral leaflets are grasped and the clip is released. Leaflet capture, residual MR, and degree of mitral stenosis are assessed post-procedure using TEE (see
         <a class="local">
          'Imaging for TEER'
         </a>
         below). If necessary, the device can be removed or repositioned, or more than one device can be deployed [
         <a href="#rid55">
          55
         </a>
         ].
        </p>
        <p>
         Further discussion of technical aspects, preoperative and postoperative care, complications, and outcomes of the MitraClip TEER procedure is found in a separate topic. (See
         <a class="medical medical_review" href="/z/d/html/99943.html" rel="external">
          "Transcatheter edge-to-edge mitral repair"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4209124073">
         <span class="h3">
          Imaging for TEER
         </span>
         <span class="headingEndMark">
          —
         </span>
         The procedure is performed using both fluoroscopy and TEE guidance. TEE is employed for preprocedural evaluation of the mitral valve to demonstrate the location of leaflet pathology, to delineate size and extent of any flail segment, and to confirm adequate leaflet length to facilitate clip placement for device implantation. Use of three-dimensional TEE enhances visualization of the mitral valve, thereby improving localization of leaflet pathology and demonstration of anatomic suitability for treatment with the device (eg, absence of cleft leaflet, vegetations, or perforations). During the procedure, TEE guidance is critical to ensure appropriate device placement, adequate reduction in MR, and maintenance of acceptable mitral inflow (ie, absence of a significant degree of mitral stenosis) which is impacted by placement of the device [
         <a href="#rid21">
          21,53,54
         </a>
         ]. While transthoracic echocardiography (TTE) guidance for a MitraClip procedure has been reported [
         <a href="#rid56">
          56
         </a>
         ], TEE is the standard imaging modality for TEER. (See
         <a class="medical medical_review" href="/z/d/html/8118.html" rel="external">
          "Pulmonic valve stenosis in adults: Management", section on 'Acute outcomes'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8118.html" rel="external">
          "Pulmonic valve stenosis in adults: Management", section on 'Balloon valvotomy'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H177392732">
         <span class="h3">
          Anesthetic techniques and management
         </span>
         <span class="headingEndMark">
          —
         </span>
         Selection of anesthetic technique for TEER varies depending on institutional preferences, patient-specific factors, and planned use of TEE. General anesthesia with endotracheal intubation is generally selected since TEE is extensively employed (see
         <a class="local">
          'Imaging for TEER'
         </a>
         above); however, moderate or deep sedation with monitored anesthesia care (MAC) has also been described [
         <a href="#rid53">
          53,57,58
         </a>
         ].
        </p>
        <p>
         A 2020 meta-analysis with five randomized and non-randomized studies compared 430 patients receiving moderate sedation (with MAC or under supervision of an interventional cardiologist) versus 217 patients receiving general anesthesia during TEER [
         <a href="#rid57">
          57
         </a>
         ]. Differences between techniques were not significant for hospital mortality, incidence of multiple clip implantation, procedure length, fluoroscopy time, eventual procedural success rate, or complications. Patients receiving sedation had a shorter intensive care unit length of stay (1.3 versus 3.8 days; standardized mean difference [SMD] = -0.97, 95% CI -1.75 to -0.20), but the difference in hospital stay was not significant (8.3 versus 10.3 days; SMD = 0.36, 95% CI -0.77 to 0.04).
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hemodynamic management
         </strong>
         – Key points for hemodynamic management of patients with MR undergoing an interventional procedure are summarized in the table  (
         <a class="graphic graphic_table graphicRef108959" href="/z/d/graphic/108959.html" rel="external">
          table 4
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Monitoring
         </strong>
         – An intra-arterial catheter is inserted and is helpful for early detection of pericardial effusion/tamponade, a recognized complication of this procedure. Placement of more invasive cardiovascular monitors (eg, central venous catheter) is not routine but may be used if peripheral access is inadequate or if vasopressor or inotropic infusions are likely. If necessary, the venous sheath placed by the procedural team for device deployment may be accessed during the procedure by the anesthesiologist [
         <a href="#rid59">
          59
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2961525891">
         <span class="h2">
          Percutaneous mitral balloon valvotomy
         </span>
        </p>
        <p class="headingAnchor" id="H3312577929">
         <span class="h3">
          General considerations
         </span>
         <span class="headingEndMark">
          —
         </span>
         Selected symptomatic patients with severe rheumatic mitral stenosis who have an anatomically favorable native valve and subvalvular features are candidates for a percutaneous mitral balloon valvotomy (PMBV) procedure. Echocardiographic criteria for candidates for PMBV are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/8161.html" rel="external">
          "Percutaneous mitral balloon commissurotomy in adults", section on 'Use'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1601068487">
         <span class="h3">
          Anesthetic techniques and management
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hemodynamic management
         </strong>
         – Key points for hemodynamic management of patients with mitral stenosis (MS) undergoing an interventional procedure are summarized in the table  (
         <a class="graphic graphic_table graphicRef108960" href="/z/d/graphic/108960.html" rel="external">
          table 5
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Anesthetic considerations and echocardiography monitoring
         </strong>
         – The PMBV procedure is usually performed with light to moderate sedation, typically administered by a nurse under the supervision of the interventional cardiologist using transthoracic and/or intracardiac echocardiography, making this procedure particularly suitable for MS patients with high surgical risk [
         <a href="#rid60">
          60
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         However, general anesthesia with endotracheal intubation may be selected for some patients to enable performance of TEE before and during the procedure, to manage potential patient discomfort, and to avoid the risks of excessive sedation in an unintubated patient including hypoxemia, hypercarbia, and exacerbation of pulmonary hypertension [
         <a href="#rid61">
          61,62
         </a>
         ]. In such cases, TEE is used immediately before PMBV to document that no more than moderate MR is present, and that there is no left atrial thrombus. Subsequently, during the procedure, TEE may be used to guide technical aspects of the PMBV procedure (eg, transseptal puncture, balloon placement) in some patients, and to monitor for complications. (See
         <a class="medical medical_review" href="/z/d/html/5329.html" rel="external">
          "Transesophageal echocardiography in the evaluation of mitral valve disease", section on 'Use for percutaneous balloon valvotomy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Further discussion of technical aspects, complications, and outcomes of the PMBV procedure is found elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/8161.html" rel="external">
          "Percutaneous mitral balloon commissurotomy in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3435468185">
         <span class="h2">
          Valve-in-valve implantation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Transcatheter valve-in-ring implantation is an option for treatment of bioprosthetic mitral valve dysfunction (stenosis or regurgitation), particularly when severe mitral valve dysfunction and/or severe annular calcification of the native valve is present [
         <a href="#rid54">
          54
         </a>
         ]. In such cases, devices used for transcatheter aortic valve implantation (TAVI) have been used in the mitral position [
         <a href="#rid63">
          63,64
         </a>
         ]. However, since the anatomy of the mitral valve differs from that of the aortic valve, placing a TAVI device in the mitral position is not ideal. Development of percutaneous mitral valve replacement devices is underway. (See
         <a class="medical medical_review" href="/z/d/html/111633.html" rel="external">
          "Bioprosthetic valve thrombosis, thromboembolism, and obstruction: Management", section on 'Mitral valve-in-valve procedure'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/112653.html" rel="external">
          "Management and prognosis of surgical aortic and mitral prosthetic valve regurgitation", section on 'Mitral valve-in-valve procedure'
         </a>
         .)
        </p>
        <p>
         General anesthesia with endotracheal intubation is generally selected for transcatheter mitral valve-in-valve or valve-in-ring replacement in order to facilitate use of TEE, although moderate sedation with MAC is feasible for selected cases [
         <a href="#rid59">
          59,65
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3032902304">
         <span class="h1">
          PULMONIC VALVE INTERVENTIONS
         </span>
        </p>
        <p class="headingAnchor" id="H57292927">
         <span class="h2">
          Percutaneous pulmonic valve implantation
         </span>
        </p>
        <p class="headingAnchor" id="H3758684954">
         <span class="h3">
          General considerations
         </span>
         <span class="headingEndMark">
          —
         </span>
         Percutaneous pulmonic valve implantation (PPVI) is indicated for selected patients with right ventricular outflow tract (RVOT) conduit (or native) severe stenosis or regurgitation. (See
         <a class="medical medical_review" href="/z/d/html/86481.html" rel="external">
          "Transcatheter pulmonary valve implantation", section on 'Clinical setting'
         </a>
         .)
        </p>
        <p>
         Notably, patients are positioned supine with arms above the head to allow appropriate fluoroscopy and the PPVI procedure may be long. Furthermore, the procedure consists of several phases including valve deployment, RVOT balloon dilation (which typically causes a precipitous drop in cardiac output), and stenting of the landing zone. If a large paravalvular leak develops after valve deployment (rare), the newly implanted pulmonic valve can be balloon dilated or, rarely, a second valve-in-valve can be deployed.
        </p>
        <p class="headingAnchor" id="H1581092817">
         <span class="h3">
          Imaging for PPVI procedures
         </span>
         <span class="headingEndMark">
          —
         </span>
         Typically fluoroscopy and, if needed, intracardiac echocardiography provide adequate imaging for PPVI procedures, so transesophageal echocardiography (TEE) is not usually required for a PPVI procedure.
        </p>
        <p class="headingAnchor" id="H1688102257">
         <span class="h3">
          Anesthetic techniques and management
         </span>
         <span class="headingEndMark">
          —
         </span>
         General anesthesia with endotracheal intubation is typically used for PPVI procedures, although moderate sedation with monitored anesthesia care (MAC) is used for selected patients in some centers [
         <a href="#rid66">
          66-68
         </a>
         ].
        </p>
        <p>
         In one case series that included 79 adults undergoing elective PPVI, all were performed with general anesthesia and endotracheal intubation, with successful extubation at the conclusion of the case in 85 percent [
         <a href="#rid69">
          69
         </a>
         ]. Three patients required mechanical ventilation for &gt;24 hours and three required reintubation. Other complications of PPVI include stent fracture, which generally has no significant hemodynamic effect but may lead to embolization of stent parts, restenosis, or conduit rupture (contained or non-contained). (See
         <a class="medical medical_review" href="/z/d/html/86481.html" rel="external">
          "Transcatheter pulmonary valve implantation", section on 'Complications by valve type'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hemodynamic management
         </strong>
         – Key points for hemodynamic management of patients with pulmonic regurgitation (PR) undergoing an interventional procedure are summarized in the table  (
         <a class="graphic graphic_table graphicRef126171" href="/z/d/graphic/126171.html" rel="external">
          table 6
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In particular, a normal to fast heart rate (HR) is maintained, since a faster HR minimizes regurgitant volume through the insufficient valve. In addition, normal to low pulmonary vascular resistance (PVR) is maintained to facilitate forward flow in the pulmonary arterial circulation. Increasing the fraction of inspired oxygen (FiO
         <sub>
          2
         </sub>
         ) and mild hyperventilation to maintain a PaCO
         <sub>
          2
         </sub>
         30 to 35 mmHg will lower PVR. Hypoxia, hypercarbia, and acidosis are avoided to prevent increases in PVR that may exacerbate right ventricular dysfunction.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          General anesthesia
         </strong>
         – A radial intra-arterial line is commonly placed. Only rarely is a separate central venous catheter inserted since the side port of the femoral or jugular venous delivery sheath can provide central venous access to the anesthesia team if necessary [
         <a href="#rid69">
          69
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Because coronary compression is a potential complication of PPVI, a balloon test to exclude potential coronary artery compression should be performed prior to valve deployment, as described separately. (See
         <a class="medical medical_review" href="/z/d/html/86481.html" rel="external">
          "Transcatheter pulmonary valve implantation", section on 'Balloon test'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         At the end of a PPVI procedure, tracheal extubation is usually possible in the procedure room or shortly thereafter. Patients are observed in the intensive care unit for at least 12 to 24 hours to detect development of complications such as pulmonary edema, hemoptysis, or bradycardia.
        </p>
        <p>
        </p>
        <p>
         Further discussion of technical aspects, complications, and outcomes of the PPVI procedure is found elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/86481.html" rel="external">
          "Transcatheter pulmonary valve implantation"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3684754715">
         <span class="h2">
          Percutaneous pulmonic balloon valvotomy
         </span>
        </p>
        <p class="headingAnchor" id="H564078096">
         <span class="h3">
          General considerations
         </span>
         <span class="headingEndMark">
          —
         </span>
         Severe pulmonic valve stenosis (PS) with a domed valve is usually treated percutaneously with pulmonic balloon valvotomy, while open cardiac surgery is reserved for patients with associated hypoplastic pulmonary annulus, dysplastic pulmonic valve, subvalvular PS, supravalvular PS, severe PR, or severe tricuspid regurgitation (TR). (See
         <a class="medical medical_review" href="/z/d/html/8118.html" rel="external">
          "Pulmonic valve stenosis in adults: Management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H717177013">
         <span class="h3">
          Anesthetic techniques and management
         </span>
         <span class="headingEndMark">
          —
         </span>
         Data regarding the choice of anesthetic technique for adults undergoing elective pulmonic balloon valvotomy are sparse [
         <a href="#rid70">
          70,71
         </a>
         ]. Many institutions use moderate sedation administered by catheterization laboratory nursing staff under the supervision of the interventionalist for this procedure. When general anesthesia with endotracheal intubation is used, extubation is usually possible at the end of the procedure.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hemodynamic management
         </strong>
         – Key points for hemodynamic management of patients with PS are summarized in the table  (
         <a class="graphic graphic_table graphicRef126171" href="/z/d/graphic/126171.html" rel="external">
          table 6
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Monitoring for complications
         </strong>
         – Use of TEE or intracardiac echocardiography may be useful to diagnose RVOT obstruction, PR, TR, pulmonary artery rupture, pulmonary edema, cardiac perforation, or tamponade in a patient who develops hemodynamic instability during or shortly after pulmonic balloon valvotomy.
        </p>
        <p>
        </p>
        <p>
         Notably, transient severe RVOT obstruction may occur shortly after relief of pulmonic valvular obstruction with balloon valvotomy [
         <a href="#rid72">
          72,73
         </a>
         ]. Such RVOT obstruction is treated with volume expansion and beta blocker therapy, and tends to lessen with time.
        </p>
        <p>
         Other acute complications of pulmonic balloon valvotomy are generally self-limited and minor. These include catheter-induced ventricular ectopy, right bundle branch block, vagal response, or transient high grade atrioventricular [AV] nodal block, which on occasion may become permanent. (See
         <a class="medical medical_review" href="/z/d/html/8118.html" rel="external">
          "Pulmonic valve stenosis in adults: Management", section on 'Acute outcomes'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8118.html" rel="external">
          "Pulmonic valve stenosis in adults: Management", section on 'Balloon valvotomy'
         </a>
         .)
        </p>
        <p>
         Further discussion of percutaneous pulmonic balloon valvotomy for treatment of severe PS is found separately. (See
         <a class="medical medical_review" href="/z/d/html/8118.html" rel="external">
          "Pulmonic valve stenosis in adults: Management", section on 'Balloon valvotomy'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H902717754">
         <span class="h1">
          TRICUSPID VALVE INTERVENTIONS
         </span>
        </p>
        <p class="headingAnchor" id="H316842818">
         <span class="h2">
          Transcatheter tricuspid valve repair
         </span>
        </p>
        <p class="headingAnchor" id="H2139984030">
         <span class="h3">
          General considerations
         </span>
         <span class="headingEndMark">
          —
         </span>
         Tricuspid regurgitation (TR) is usually secondary to other pathology such as left-sided heart failure, left-sided valvular disease, and pulmonary hypertension, but correction of the primary underlying condition may not reverse secondary TR. TR as a result of a primary condition affecting the tricuspid valve apparatus is less common than secondary or functional TR. Causes of primary TR include iatrogenic injury of the valve, infective endocarditis, rheumatic heart disease, carcinoid syndrome, and Ebstein anomaly. (See
         <a class="medical medical_review" href="/z/d/html/8119.html" rel="external">
          "Etiology, clinical features, and evaluation of tricuspid regurgitation", section on 'Etiology'
         </a>
         .)
        </p>
        <p>
         When left-sided valve surgery is performed, concomitant surgical repair of the tricuspid valve is indicated for severe TR and may be helpful for selected patients with less than severe TR [
         <a href="#rid47">
          47
         </a>
         ]. In selected patients, isolated surgical repair for severe TR may be indicated. Management details are discussed in separate topics. (See
         <a class="medical medical_review" href="/z/d/html/8145.html" rel="external">
          "Management and prognosis of tricuspid regurgitation", section on 'Tricuspid valve surgery'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8145.html" rel="external">
          "Management and prognosis of tricuspid regurgitation", section on 'Transcatheter tricuspid valve repair'
         </a>
         .)
        </p>
        <p>
         Selected patients who are not undergoing open left-sided cardiac valve surgery may be candidates for transcatheter tricuspid valve repair, typically those with moderate to severe central secondary TR without severely impaired RV function [
         <a href="#rid74">
          74,75
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/8145.html" rel="external">
          "Management and prognosis of tricuspid regurgitation", section on 'Timing and risk stratification'
         </a>
         ). Devices that are approved for this purpose in Europe (ie, Triclip and PASCAL devices) are investigational in the United States, and other devices are undergoing feasibility testing. (See
         <a class="medical medical_review" href="/z/d/html/8145.html" rel="external">
          "Management and prognosis of tricuspid regurgitation", section on 'Transcatheter tricuspid valve repair'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H974183550">
         <span class="h3">
          Imaging for transcatheter tricuspid valve repair procedures
         </span>
         <span class="headingEndMark">
          —
         </span>
         Typically, combinations of fluoroscopy and echocardiography (transesophageal echocardiography [TEE] and/or intracardiac echocardiography [ICE]) are used for procedural guidance. ICE may be used in conjunction with TEE as TV leaflets may not be clearly defined using TEE alone. When extensive use of TEE is planned, general anesthesia with endotracheal intubation is usually selected.
        </p>
        <p class="headingAnchor" id="H1151020763">
         <span class="h3">
          Anesthetic techniques and management
         </span>
         <span class="headingEndMark">
          —
         </span>
         The procedural steps for transcatheter tricuspid valve repair vary depending on the device to be implanted, which may impact anesthetic management. Initial reports from the multicenter International TriValve Registry with data on 106 high-risk patients treated with transcatheter tricuspid valve devices have noted that all but one of the procedures had been performed using general anesthesia with endotracheal intubation [
         <a href="#rid74">
          74,75
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hemodynamic management
         </strong>
         – Hemodynamic goals for patients with TR undergoing an interventional procedure include maintenance of a normal to fast heart rate (HR) at 80 to 100 beats per minute (bpm) because a faster HR minimizes regurgitant volume. Maintenance of a normal to low pulmonary vascular resistance (PVR) facilitates forward flow in the pulmonary arterial circulation. Avoidance of hypoxia, hypercarbia, and acidosis is particularly important to prevent increases in PVR which may exacerbate RV dysfunction. Systemic vascular resistance (SVR) is maintained in the normal range. (See
         <a class="medical medical_review" href="/z/d/html/91483.html" rel="external">
          "Anesthesia for cardiac valve surgery", section on 'Surgery for tricuspid valve disease'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Anesthetic techniques
         </strong>
         – Initial reports from the multicenter International TriValve Registry note that an intra-arterial catheter is usually inserted [
         <a href="#rid74">
          74,75
         </a>
         ]. Placement of more invasive cardiovascular monitors (eg, central venous catheter) is not routine. Patients are recovered in a high-dependency setting or an intensive care unit [
         <a href="#rid76">
          76
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8145.html" rel="external">
          "Management and prognosis of tricuspid regurgitation", section on 'Transcatheter tricuspid valve repair'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2525970331">
         <span class="h2">
          Percutaneous tricuspid balloon valvotomy
         </span>
        </p>
        <p class="headingAnchor" id="H1540156887">
         <span class="h3">
          General considerations
         </span>
         <span class="headingEndMark">
          —
         </span>
         The most common cause of tricuspid stenosis (TS) in adults is rheumatic heart disease. These patients may also have coexisting TR and/or other cardiac valve lesions, but severe, symptomatic TS without TR or other cardiac valve disease is rare [
         <a href="#rid77">
          77,78
         </a>
         ]. The choice between tricuspid valve surgery (repair or replacement) or percutaneous balloon valvotomy of the tricuspid valve is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/8136.html" rel="external">
          "Tricuspid stenosis", section on 'Treatment'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2223240142">
         <span class="h3">
          Anesthetic techniques and management
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hemodynamic management
         </strong>
         – Hemodynamic goals for patients with TS undergoing an interventional procedure include maintenance of a normal to slow HR at 60 to 80 bpm, a normal to low PVR, and a normal SVR. (See
         <a class="medical medical_review" href="/z/d/html/91483.html" rel="external">
          "Anesthesia for cardiac valve surgery", section on 'Surgery for tricuspid valve disease'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Anesthetic techniques
         </strong>
         – Percutaneous tricuspid balloon valvotomy is usually performed with moderate sedation using transthoracic and/or intracardiac echocardiography. However, in some patients, TEE may be desired to guide technical aspects of the procedure. or to monitor for complications. In these cases, general anesthesia with endotracheal intubation is preferred.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1404099597">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/115482.html" rel="external">
          "Society guideline links: Cardiac valve disease"
         </a>
         and
         <a class="medical medical_society_guidelines" href="/z/d/html/120365.html" rel="external">
          "Society guideline links: Transcatheter aortic valve implantation"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1454894838">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Location for procedures
         </strong>
         –
         <strong>
         </strong>
         Percutaneous valve interventions require a multidisciplinary team (ie, interventional cardiologist, cardiac surgeon, imaging specialist/radiologist, cardiac anesthesiologist, and perfusionist to provide back-up cardiopulmonary bypass [CPB] if needed). (See
         <a class="local">
          'Team and location'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Anesthetic technique
         </strong>
         – Percutaneous valve interventions are performed with either general anesthesia with endotracheal intubation or sedation (generally moderate; with or without monitored anesthesia care [MAC]) with general anesthesia back-up. The anesthesia technique is selected depending on the specific procedure, institutional preferences, and patient-specific factors. General anesthesia is generally required if transesophageal echocardiography (TEE) is planned. With either technique, short-acting anesthetic agents are preferred and normothermia is maintained to ensure rapid awakening and recovery. (See
         <a class="local">
          'Selection of anesthesia technique'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          General anesthesia
         </strong>
         – Short-acting intravenous (IV) anesthetic agents such as
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         ,
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         or
         <a class="drug drug_general" data-topicid="9854" href="/z/d/drug information/9854.html" rel="external">
          remifentanil
         </a>
         ,
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          midazolam
         </a>
         ,
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          ketamine
         </a>
         , and/or a volatile inhalation anesthetic, as well as a short-acting neuromuscular blocking agent (NMBA) are preferred to facilitate rapid awakening and recovery. (See
         <a class="local">
          'General anesthesia'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Sedation with monitored anesthesia care (MAC)
         </strong>
         – Anesthetic agents typically include a low dose
         <a class="drug drug_general" data-topicid="9854" href="/z/d/drug information/9854.html" rel="external">
          remifentanil
         </a>
         infusion or a low dose
         <a class="drug drug_general" data-topicid="8897" href="/z/d/drug information/8897.html" rel="external">
          dexmedetomidine
         </a>
         infusion. If needed small dose(s) of intravenous (IV)
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          midazolam
         </a>
         are added. If an additional anesthetic agent is required to achieve the desired depth of sedation,
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         may be administered. (See
         <a class="local">
          'Moderate sedation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Aortic valve procedures
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Transcatheter aortic valve implantation (TAVI)
         </strong>
         – TAVI is used predominantly to treat severe aortic stenosis (AS) but is also used for selected patients with aortic regurgitation (AR; investigational in the US)  (
         <a class="graphic graphic_figure graphicRef109286" href="/z/d/graphic/109286.html" rel="external">
          figure 1
         </a>
         ). For TAVI, selection of anesthetic technique for an individual patient includes consideration of center and operator practice, patient comorbidities, planned use of TEE, and the TAVI access route. Although an intra-arterial catheter and TEE are usually inserted for patients undergoing general anesthesia, use of a full complement of invasive cardiovascular monitors (eg, central venous catheter) is decreasing. Key points for hemodynamic management of patients with AS and for patients with AR are summarized in tables  (
         <a class="graphic graphic_table graphicRef108941" href="/z/d/graphic/108941.html" rel="external">
          table 3
         </a>
         and
         <a class="graphic graphic_table graphicRef108959" href="/z/d/graphic/108959.html" rel="external">
          table 4
         </a>
         ). (See
         <a class="local">
          'Transcatheter aortic valve implantation'
         </a>
         above and
         <a class="local">
          'Anesthetic techniques and management'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Transfemoral TAVI is most common, and may be performed with either moderate sedation with MAC and local or regional anesthetic techniques or with general anesthesia.
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Procedures via other access routes (eg, subclavian/axillary, transaortic or transapical, transcaval, transcarotid) are usually performed with general anesthesia, although some centers use moderate sedation with MAC in selected patients.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Percutaneous balloon aortic valvotomy
         </strong>
         –
         <strong>
         </strong>
         Balloon valvotomy for severe AS is generally performed using local anesthesia and light-to-moderate sedation. (See
         <a class="local">
          'Percutaneous balloon aortic valvotomy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Mitral valve procedures
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Transcatheter edge-to-edge mitral repair (TEER)
         </strong>
         – The TEER "beating heart" approach to treat MR has the advantage of use of real-time TEE to assess adequacy of correction so that immediate intra-procedural adjustments may be made if necessary  (
         <a class="graphic graphic_figure graphicRef116916" href="/z/d/graphic/116916.html" rel="external">
          figure 2
         </a>
         ). Key points for hemodynamic management of patients with MR are summarized in the table  (
         <a class="graphic graphic_table graphicRef108959" href="/z/d/graphic/108959.html" rel="external">
          table 4
         </a>
         ). General anesthesia is usually selected for TEER procedures since TEE is extensively employed, although use of moderate sedation or MAC has also been described. (See
         <a class="local">
          'Transcatheter edge-to-edge mitral repair'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Percutaneous mitral balloon valvotomy (PMBV)
         </strong>
         – Balloon valvotomy is an option for selected patients with MS. PMBV is usually performed with minimal sedation using transthoracic echocardiography (TTE). However, if TEE is planned to guide the procedure during transseptal puncture and balloon placement as well as monitoring for complications, then general anesthesia with endotracheal intubation is typically necessary. Key points for hemodynamic management of patients with MS are summarized in the table  (
         <a class="graphic graphic_table graphicRef108960" href="/z/d/graphic/108960.html" rel="external">
          table 5
         </a>
         ). (See
         <a class="local">
          'Percutaneous mitral balloon valvotomy'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/8161.html" rel="external">
          "Percutaneous mitral balloon commissurotomy in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pulmonic valve procedures
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Percutaneous pulmonic valve implantation (PPVI)
         </strong>
         – PPVI is indicated for selected patients with right ventricular outflow tract (RVOT) conduit (or native) severe stenosis or regurgitation. General anesthesia with endotracheal intubation is usually employed. Key points for hemodynamic management of patients with pulmonic regurgitation (PR) are summarized in the table  (
         <a class="graphic graphic_table graphicRef126171" href="/z/d/graphic/126171.html" rel="external">
          table 6
         </a>
         ). (See
         <a class="local">
          'Percutaneous pulmonic valve implantation'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/86481.html" rel="external">
          "Transcatheter pulmonary valve implantation"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Percutaneous pulmonic balloon valvotomy
         </strong>
         – Balloon valvotomy may be used for selected patients with severe pulmonic stenosis (PS) and a domed valve. Sedation is employed more commonly than general anesthesia. Key points for hemodynamic management of patients with PS are summarized in the table  (
         <a class="graphic graphic_table graphicRef126171" href="/z/d/graphic/126171.html" rel="external">
          table 6
         </a>
         ). (See
         <a class="local">
          'Percutaneous pulmonic balloon valvotomy'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/8118.html" rel="external">
          "Pulmonic valve stenosis in adults: Management", section on 'Indications for intervention'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Tricuspid valve procedures
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Tricuspid regurgitation (TR) procedures
         </strong>
         –
         <strong>
         </strong>
         Transcatheter tricuspid valve repair of TR is usually performed with general anesthesia. TEE is utilized. Intracardiac echocardiography (ICE) can be used as an adjunct to help define TV leaflets. Hemodynamic goals for patients with TR include maintenance of a normal to fast heart rate (HR) at 80 to 100 beats per minute (bpm), normal to low pulmonary vascular resistance (PVR), avoidance of hypoxia, hypercarbia, and acidosis to prevent increases in PVR which may exacerbate RV dysfunction, and normal systemic vascular resistance (SVR). (See
         <a class="local">
          'Transcatheter tricuspid valve repair'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/8145.html" rel="external">
          "Management and prognosis of tricuspid regurgitation", section on 'Transcatheter tricuspid valve repair'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Percutaneous tricuspid balloon valvotomy
         </strong>
         – Balloon valvotomy for patients with tricuspid stenosis (TS) is usually performed with moderate sedation using TTE and/or intracardiac echocardiography, but general anesthesia may be employed if TEE use is planned. Hemodynamic goals for patients with TS include maintenance of a normal to slow HR at 60 to 80 bpm, normal to low PVR, and normal SVR. (See
         <a class="local">
          'Percutaneous tricuspid balloon valvotomy'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/8136.html" rel="external">
          "Tricuspid stenosis", section on 'Intervention'
         </a>
         .)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Bavaria JE, Tommaso CL, Brindis RG, et al. 2018 AATS/ACC/SCAI/STS Expert Consensus Systems of Care Document: Operator and Institutional Recommendations and Requirements for Transcatheter Aortic Valve Replacement: A Joint Report of the American Association for Thoracic Surgery, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2019; 73:340.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Babaliaros V, Devireddy C, Lerakis S, et al. Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis. JACC Cardiovasc Interv 2014; 7:898.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Neuburger PJ, Patel PA. Anesthetic Techniques in Transcatheter Aortic Valve Replacement and the Evolving Role of the Anesthesiologist. J Cardiothorac Vasc Anesth 2017; 31:2175.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang HQ, Zhang X, Zhang TZ. Advances in the Anesthetic Management of Transcatheter Aortic Valve Implantation. J Cardiothorac Vasc Anesth 2018; 32:1464.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Doan V, Liu Y, Teeter EG, et al. Propofol Versus Remifentanil Sedation for Transcatheter Aortic Valve Replacement: A Single Academic Center Experience. J Cardiothorac Vasc Anesth 2022; 36:103.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Finley AC, Sniecinski R. How Deep to Sleep for Procedural Echocardiography? J Am Soc Echocardiogr 2018; 31:A32.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goeddel LA, Abernathy JH, Brady MB. An Anesthesiologist's Guide to the 2017 American College of Cardiology Expert Consensus Decision Pathway for Transcatheter Aortic Valve Replacement in the Management of Adults with Aortic Stenosis. J Cardiothorac Vasc Anesth 2019; 33:263.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kimmel J, Potosky R, Williams MR, et al. Conversion from Monitored Anesthesia Care to General Anesthesia for Transcatheter Aortic Valve Replacement. J Cardiothorac Vasc Anesth 2018; 32:1032.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patel PA, Ackermann AM, Augoustides JGT, et al. Anesthetic Evolution in Transcatheter Aortic Valve Replacement: Expert Perspectives From High-Volume Academic Centers in Europe and the United States. J Cardiothorac Vasc Anesth 2017; 31:777.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cormican D, McHugh S, Boisen M, et al. The Low Risk Transcatheter Aortic Valve Replacement Trials-An Analysis. J Cardiothorac Vasc Anesth 2020; 34:3133.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carroll JD, Mack MJ, Vemulapalli S, et al. STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement. J Am Coll Cardiol 2020; 76:2492.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhu D, Hu J, Meng W, Guo Y. Successful transcatheter aortic valve implantation for pure aortic regurgitation using a new second generation self-expanding J-Valve(TM) system - the first in-man implantation. Heart Lung Circ 2015; 24:411.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reul RM, Ramchandani MK, Reardon MJ. Transcatheter Aortic Valve-in-Valve Procedure in Patients with Bioprosthetic Structural Valve Deterioration. Methodist Debakey Cardiovasc J 2017; 13:132.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lefèvre G, Jégou A, Dambrin G, et al. Comparison of TransFemoral Transcatheter Aortic Valve Replacement Performed With a Minimally Invasive Simplified Technique: "FAST" Versus a Standard Approach. J Invasive Cardiol 2019; 31:300.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hyman MC, Vemulapalli S, Szeto WY, et al. Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Insights from the National Cardiovascular Data Registry Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. Circulation 2017; 136:2132.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pospishil L, Nampi RG, Neuburger PJ. Contemporary Practice of Echocardiography in Transcatheter Aortic Valve Replacement. J Cardiothorac Vasc Anesth 2022; 36:4.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maldonado Y, Baisden J, Villablanca PA, et al. General Anesthesia Versus Conscious Sedation for Transcatheter Aortic Valve Replacement-An Analysis of Current Outcome Data. J Cardiothorac Vasc Anesth 2018; 32:1081.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Teeter EG, Dakik C, Cooter M, et al. Assessment of Paravalvular Leak After Transcatheter Aortic Valve Replacement: Transesophageal Echocardiography Compared With Transthoracic Echocardiography. J Cardiothorac Vasc Anesth 2017; 31:1278.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tamburino C, Capodanno D, Ramondo A, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 2011; 123:299.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012; 366:1686.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hoffmeister KJ, Henderson ZT, Hussey PT, Wu IY. Guidelines for the Evaluation of Valvular Regurgitation After Percutaneous Valve Repair or Replacement: A Focused Review for the Cardiac Anesthesiologist. J Cardiothorac Vasc Anesth 2020; 34:2740.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Del Val D, Ferreira-Neto AN, Asmarats L, et al. Transcatheter aortic valve replacement: relative safety and efficacy of the procedure with different devices. Expert Rev Med Devices 2019; 16:11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sniecinski RM, Mackensen GB, Kertai MD. Letter by Sniecinski et al Regarding Article, "Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Insights from the National Cardiovascular Data Registry Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry". Circulation 2018; 137:2543.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mayr NP. Transfemoral Transcatheter Aortic Valve Replacement: Conscious Sedation for Everyone? JACC Cardiovasc Interv 2020; 13:1288.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Butala NM, Chung M, Secemsky EA, et al. Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Variation in Practice and Outcomes. JACC Cardiovasc Interv 2020; 13:1277.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sato K, Jones PM. Sedation versus general anesthesia for transcatheter aortic valve replacement. J Thorac Dis 2018; 10:S3588.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brown CH 4th, Hasan RK, Brady MB. Is Less Really More? Conscious Sedation or General Anesthesia for Transcatheter Aortic Valve Replacement. Circulation 2017; 136:2141.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thiele H, Kurz T, Feistritzer HJ, et al. General Versus Local Anesthesia With Conscious Sedation in Transcatheter Aortic Valve Implantation: The Randomized SOLVE-TAVI Trial. Circulation 2020; 142:1437.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Husser O, Fujita B, Hengstenberg C, et al. Conscious Sedation Versus General Anesthesia in Transcatheter Aortic Valve Replacement: The German Aortic Valve Registry. JACC Cardiovasc Interv 2018; 11:567.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mosleh W, Mather JF, Amer MR, et al. Propensity Matched Analysis Comparing Conscious Sedation Versus General Anesthesia in Transcatheter Aortic Valve Implantation. Am J Cardiol 2019; 124:70.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pani S, Cagino J, Feustel P, et al. Patient Selection and Outcomes of Transfemoral Transcatheter Aortic Valve Replacement Performed with Monitored Anesthesia Care Versus General Anesthesia. J Cardiothorac Vasc Anesth 2017; 31:2049.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bianco V, Gleason TG, Kilic A, et al. Open Surgical Access for Transfemoral TAVR Should Not Be a Contraindication for Conscious Sedation. J Cardiothorac Vasc Anesth 2019; 33:39.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Block M, Pitchon DN, Schwenk ES, et al. Left Subclavian Transcatheter Aortic Valve Replacement Under Combined Interscalene and Pectoralis Nerve Blocks: A Case Series. A A Pract 2018; 11:332.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ip V, Achen B, Nagendran J. Subclavian transcatheter aortic valve implantation (TAVI): superficial cervical plexus block combined with low-dose interscalene block. Can J Anaesth 2020; 67:1389.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berthoud V, Ellouze O, Bièvre T, et al. Serratus Anterior Plane Block for Apical TAVR in an Awake Patient. J Cardiothorac Vasc Anesth 2018; 32:2275.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Overtchouk P, Alqdeimat I, Coisne A, et al. Transcarotid approach for TAVI: an optimal alternative to the transfemoral gold standard. Ann Cardiothorac Surg 2017; 6:555.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Debry N, Delhaye C, Azmoun A, et al. Transcarotid Transcatheter Aortic Valve Replacement: General or Local Anesthesia. JACC Cardiovasc Interv 2016; 9:2113.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363:1597.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Otto CM, Kumbhani DJ, Alexander KP, et al. 2017 ACC Expert Consensus Decision Pathway for Transcatheter Aortic Valve Replacement in the Management of Adults With Aortic Stenosis: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2017; 69:1313.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mayr NP, Hapfelmeier A, Martin K, et al. Comparison of sedation and general anaesthesia for transcatheter aortic valve implantation on cerebral oxygen saturation and neurocognitive outcome†. Br J Anaesth 2016; 116:90.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zaouter C, Hemmerling TM, Mion S, et al. Feasibility of Automated Propofol Sedation for Transcatheter Aortic Valve Implantation: A Pilot Study. Anesth Analg 2017; 125:1505.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mayr NP, Wiesner G, van der Starre P, et al. Dexmedetomidine versus propofol-opioid for sedation in transcatheter aortic valve implantation patients: a retrospective analysis of periprocedural gas exchange and hemodynamic support. Can J Anaesth 2018; 65:647.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khalil M, Al-Agaty A, Asaad O, et al. A comparative study between propofol and dexmedetomidine as sedative agents during performing transcatheter aortic valve implantation. J Clin Anesth 2016; 32:242.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mayr NP, Michel J, Bleiziffer S, et al. Sedation or general anesthesia for transcatheter aortic valve implantation (TAVI). J Thorac Dis 2015; 7:1518.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ben-Dor I, Looser PM, Maluenda G, et al. Transcatheter aortic valve replacement under monitored anesthesia care versus general anesthesia with intubation. Cardiovasc Revasc Med 2012; 13:207.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bergmann L, Kahlert P, Eggebrecht H, et al. Transfemoral aortic valve implantation under sedation and monitored anaesthetic care--a feasibility study. Anaesthesia 2011; 66:977.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg 2014; 148:e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chacko M, Weinberg L. Aortic valve stenosis: perioperative anaesthetic implications of surgical replacement and minimally invasive interventions. Continuing Education in Anaesthesia Critical Care &amp; Pain 2012; 12:295.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Feldman T, Kar S, Rinaldi M, et al. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol 2009; 54:686.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kavakli AS, Ozturk NK, Ayoglu RU, et al. Anesthetic Management of Transapical Off-Pump Mitral Valve Repair With NeoChord Implantation. J Cardiothorac Vasc Anesth 2016; 30:1587.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Glauber M, Miceli A. State of the art for approaching the mitral valve: sternotomy, minimally invasive or total endoscopic robotic? Eur J Cardiothorac Surg 2015; 48:639.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gammie JS, Bartus K, Gackowski A, et al. Beating-Heart Mitral Valve Repair Using a Novel ePTFE Cordal Implantation Device: A Prospective Trial. J Am Coll Cardiol 2018; 71:25.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wu IY, Barajas MB, Hahn RT. The MitraClip Procedure-A Comprehensive Review for the Cardiac Anesthesiologist. J Cardiothorac Vasc Anesth 2018; 32:2746.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fernando RJ, Shah R, Yang Y, et al. Transcatheter Mitral Valve Repair and Replacement: Analysis of Recent Data and Outcomes. J Cardiothorac Vasc Anesth 2020; 34:2793.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kothandan H, Vui KH, Khung KY, Nian CH. Anesthesia management for MitraClip device implantation. Ann Card Anaesth 2014; 17:17.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Musuku SR, Yukhvid D, Kadakuntla A, Shapeton AD. Transthoracic Echocardiography Guidance for MitraClip Procedure. J Cardiothorac Vasc Anesth 2022; 36:222.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Banga S, Hafiz AM, Chami Y, et al. Comparing sedation vs. general anaesthesia in transoesophageal echocardiography-guided percutaneous transcatheter mitral valve repair: a meta-analysis. Eur Heart J Cardiovasc Imaging 2020; 21:511.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chan JSK, Kot TKM, Ghani S, Harky A. Local anaesthesia and deep sedation versus general anaesthesia for transcatheter mitral edge-to-edge repair: A systematic review and meta-analysis. J Clin Anesth 2020; 65:109816.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gregory SH, Sodhi N, Zoller JK, et al. Anesthetic Considerations for the Transcatheter Management of Mitral Valve Disease. J Cardiothorac Vasc Anesth 2019; 33:796.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Passeri JJ, Dal-Bianco JP. Percutaneous Balloon Mitral Valvuloplasty: Echocardiographic Eligibility and Procedural Guidance. Interv Cardiol Clin 2018; 7:405.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cavalcante JL, Rodriguez LL, Kapadia S, et al. Role of echocardiography in percutaneous mitral valve interventions. JACC Cardiovasc Imaging 2012; 5:733.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Modak SD, Kane DG. Conscious sedation for balloon mitral valvotomy: A comparison of fentanyl versus sufentanil. Ann Card Anaesth 2017; 20:163.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zanobini M, Manganiello S, Bonalumi G, et al. Emergency transapical mitral valve-in-valve implantation for bioprosthesis failure: transapical implantation of an Edwards Sapien-XT in a dysfunctional mitral bioprosthesis in a critical patient. J Cardiothorac Surg 2017; 12:114.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Condado JF, Kaebnick B, Babaliaros V. Transcatheter Mitral Valve-in-Valve Therapy. Interv Cardiol Clin 2016; 5:117.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Latib A, Ielasi A, Montorfano M, et al. Transcatheter valve-in-valve implantation with the Edwards SAPIEN in patients with bioprosthetic heart valve failure: the Milan experience. EuroIntervention 2012; 7:1275.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Butera G, Milanesi O, Spadoni I, et al. Melody transcatheter pulmonary valve implantation. Results from the registry of the Italian Society of Pediatric Cardiology. Catheter Cardiovasc Interv 2013; 81:310.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lurz P, Coats L, Khambadkone S, et al. Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome. Circulation 2008; 117:1964.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McElhinney DB, Hennesen JT. The Melody® valve and Ensemble® delivery system for transcatheter pulmonary valve replacement. Ann N Y Acad Sci 2013; 1291:77.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arboleda Salazar R, Heggie J, Wolski P, et al. Anesthesia for Percutaneous Pulmonary Valve Implantation: A Case Series. Anesth Analg 2018; 127:39.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rao PS. Percutaneous balloon pulmonary valvuloplasty: state of the art. Catheter Cardiovasc Interv 2007; 69:747.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lanjewar C, Phadke M, Singh A, et al. Percutaneous balloon valvuloplasty with Inoue balloon catheter technique for pulmonary valve stenosis in adolescents and adults. Indian Heart J 2017; 69:176.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fontes VF, Esteves CA, Sousa JE, et al. Regression of infundibular hypertrophy after pulmonary valvuloplasty for pulmonic stenosis. Am J Cardiol 1988; 62:977.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thapar MK, Rao PS. Significance of infundibular obstruction following balloon valvuloplasty for valvar pulmonic stenosis. Am Heart J 1989; 118:99.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taramasso M, Hahn RT, Alessandrini H, et al. The International Multicenter TriValve Registry: Which Patients Are Undergoing Transcatheter Tricuspid Repair? JACC Cardiovasc Interv 2017; 10:1982.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taramasso M, Alessandrini H, Latib A, et al. Outcomes After Current Transcatheter Tricuspid Valve Intervention: Mid-Term Results From the International TriValve Registry. JACC Cardiovasc Interv 2019; 12:155.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zoller JK, Gregory SH. Anesthetic Considerations for Transcatheter Tricuspid Valve Repair. J Cardiothorac Vasc Anesth 2020; 34:1942.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hauck AJ, Freeman DP, Ackermann DM, et al. Surgical pathology of the tricuspid valve: a study of 363 cases spanning 25 years. Mayo Clin Proc 1988; 63:851.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Daniels SJ, Mintz GS, Kotler MN. Rheumatic tricuspid valve disease: two-dimensional echocardiographic, hemodynamic, and angiographic correlations. Am J Cardiol 1983; 51:492.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 102860 Version 9.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30031107" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : 2018 AATS/ACC/SCAI/STS Expert Consensus Systems of Care Document: Operator and Institutional Recommendations and Requirements for Transcatheter Aortic Valve Replacement: A Joint Report of the American Association for Thoracic Surgery, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25086843" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28676187" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Anesthetic Techniques in Transcatheter Aortic Valve Replacement and the Evolving Role of the Anesthesiologist.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29426651" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Advances in the Anesthetic Management of Transcatheter Aortic Valve Implantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34074554" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Propofol Versus Remifentanil Sedation for Transcatheter Aortic Valve Replacement: A Single Academic Center Experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29306367" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : How Deep to Sleep for Procedural Echocardiography?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29935802" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : An Anesthesiologist's Guide to the 2017 American College of Cardiology Expert Consensus Decision Pathway for Transcatheter Aortic Valve Replacement in the Management of Adults with Aortic Stenosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29336966" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Conversion from Monitored Anesthesia Care to General Anesthesia for Transcatheter Aortic Valve Replacement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28476446" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Anesthetic Evolution in Transcatheter Aortic Valve Replacement: Expert Perspectives From High-Volume Academic Centers in Europe and the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32144060" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : The Low Risk Transcatheter Aortic Valve Replacement Trials-An Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33213729" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25465513" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Successful transcatheter aortic valve implantation for pure aortic regurgitation using a new second generation self-expanding J-Valve(TM) system - the first in-man implantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29743998" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Transcatheter Aortic Valve-in-Valve Procedure in Patients with Bioprosthetic Structural Valve Deterioration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31567114" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Comparison of TransFemoral Transcatheter Aortic Valve Replacement Performed With a Minimally Invasive Simplified Technique: "FAST" Versus a Standard Approach.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28864443" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Insights from the National Cardiovascular Data Registry Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34366216" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Contemporary Practice of Echocardiography in Transcatheter Aortic Valve Replacement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29338998" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : General Anesthesia Versus Conscious Sedation for Transcatheter Aortic Valve Replacement-An Analysis of Current Outcome Data.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28800985" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Assessment of Paravalvular Leak After Transcatheter Aortic Valve Replacement: Transesophageal Echocardiography Compared With Transthoracic Echocardiography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21220731" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22443479" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Two-year outcomes after transcatheter or surgical aortic-valve replacement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31959400" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Guidelines for the Evaluation of Valvular Regurgitation After Percutaneous Valve Repair or Replacement: A Focused Review for the Cardiac Anesthesiologist.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30526139" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Transcatheter aortic valve replacement: relative safety and efficacy of the procedure with different devices.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29866782" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Letter by Sniecinski et al Regarding Article, "Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Insights from the National Cardiovascular Data Registry Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry".
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32499019" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Transfemoral Transcatheter Aortic Valve Replacement: Conscious Sedation for Everyone?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32499018" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Variation in Practice and Outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30505539" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Sedation versus general anesthesia for transcatheter aortic valve replacement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29180493" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Is Less Really More? Conscious Sedation or General Anesthesia for Transcatheter Aortic Valve Replacement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32819145" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : General Versus Local Anesthesia With Conscious Sedation in Transcatheter Aortic Valve Implantation: The Randomized SOLVE-TAVI Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29566803" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Conscious Sedation Versus General Anesthesia in Transcatheter Aortic Valve Replacement: The German Aortic Valve Registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31064667" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Propensity Matched Analysis Comparing Conscious Sedation Versus General Anesthesia in Transcatheter Aortic Valve Implantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28911896" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Patient Selection and Outcomes of Transfemoral Transcatheter Aortic Valve Replacement Performed with Monitored Anesthesia Care Versus General Anesthesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30458980" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Open Surgical Access for Transfemoral TAVR Should Not Be a Contraindication for Conscious Sedation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29927758" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Left Subclavian Transcatheter Aortic Valve Replacement Under Combined Interscalene and Pectoralis Nerve Blocks: A Case Series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32666424" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Subclavian transcatheter aortic valve implantation (TAVI): superficial cervical plexus block combined with low-dose interscalene block.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29398382" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Serratus Anterior Plane Block for Apical TAVR in an Awake Patient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29062754" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Transcarotid approach for TAVI: an optimal alternative to the transfemoral gold standard.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27765304" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Transcarotid Transcatheter Aortic Valve Replacement: General or Local Anesthesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20961243" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28063810" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : 2017 ACC Expert Consensus Decision Pathway for Transcatheter Aortic Valve Replacement in the Management of Adults With Aortic Stenosis: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26424178" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Comparison of sedation and general anaesthesia for transcatheter aortic valve implantation on cerebral oxygen saturation and neurocognitive outcome†.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28027088" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Feasibility of Automated Propofol Sedation for Transcatheter Aortic Valve Implantation: A Pilot Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29464420" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Dexmedetomidine versus propofol-opioid for sedation in transcatheter aortic valve implantation patients: a retrospective analysis of periprocedural gas exchange and hemodynamic support.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27290982" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : A comparative study between propofol and dexmedetomidine as sedative agents during performing transcatheter aortic valve implantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26543597" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Sedation or general anesthesia for transcatheter aortic valve implantation (TAVI).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22818531" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Transcatheter aortic valve replacement under monitored anesthesia care versus general anesthesia with intubation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21933156" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Transfemoral aortic valve implantation under sedation and monitored anaesthetic care--a feasibility study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24939033" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Aortic valve stenosis: perioperative anaesthetic implications of surgical replacement and minimally invasive interventions
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19679246" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27671218" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Anesthetic Management of Transapical Off-Pump Mitral Valve Repair With NeoChord Implantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26387147" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : State of the art for approaching the mitral valve: sternotomy, minimally invasive or total endoscopic robotic?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29102688" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Beating-Heart Mitral Valve Repair Using a Novel ePTFE Cordal Implantation Device: A Prospective Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30268642" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : The MitraClip Procedure-A Comprehensive Review for the Cardiac Anesthesiologist.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32151510" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Transcatheter Mitral Valve Repair and Replacement: Analysis of Recent Data and Outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24401297" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Anesthesia management for MitraClip device implantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33162305" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Transthoracic Echocardiography Guidance for MitraClip Procedure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32101610" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Comparing sedation vs. general anaesthesia in transoesophageal echocardiography-guided percutaneous transcatheter mitral valve repair: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32470836" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Local anaesthesia and deep sedation versus general anaesthesia for transcatheter mitral edge-to-edge repair: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30064851" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Anesthetic Considerations for the Transcatheter Management of Mitral Valve Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29983151" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Percutaneous Balloon Mitral Valvuloplasty: Echocardiographic Eligibility and Procedural Guidance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22789942" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Role of echocardiography in percutaneous mitral valve interventions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28393775" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Conscious sedation for balloon mitral valvotomy: A comparison of fentanyl versus sufentanil.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29237501" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Emergency transapical mitral valve-in-valve implantation for bioprosthesis failure: transapical implantation of an Edwards Sapien-XT in a dysfunctional mitral bioprosthesis in a critical patient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27852478" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Transcatheter Mitral Valve-in-Valve Therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22278193" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Transcatheter valve-in-valve implantation with the Edwards SAPIEN in patients with bioprosthetic heart valve failure: the Milan experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22718682" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Melody transcatheter pulmonary valve implantation. Results from the registry of the Italian Society of Pediatric Cardiology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18391109" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23834411" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : The Melody®valve and Ensemble®delivery system for transcatheter pulmonary valve replacement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29543640" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Anesthesia for Percutaneous Pulmonary Valve Implantation: A Case Series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17330270" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Percutaneous balloon pulmonary valvuloplasty: state of the art.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28460765" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Percutaneous balloon valvuloplasty with Inoue balloon catheter technique for pulmonary valve stenosis in adolescents and adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3177246" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Regression of infundibular hypertrophy after pulmonary valvuloplasty for pulmonic stenosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2741801" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Significance of infundibular obstruction following balloon valvuloplasty for valvar pulmonic stenosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28982563" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : The International Multicenter TriValve Registry: Which Patients Are Undergoing Transcatheter Tricuspid Repair?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30594510" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Outcomes After Current Transcatheter Tricuspid Valve Intervention: Mid-Term Results From the International TriValve Registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31761655" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Anesthetic Considerations for Transcatheter Tricuspid Valve Repair.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3045434" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Surgical pathology of the tricuspid valve: a study of 363 cases spanning 25 years.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6823865" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Rheumatic tricuspid valve disease: two-dimensional echocardiographic, hemodynamic, and angiographic correlations.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
